Single molecules having mixed CDK4, CDK6, PLK1 targeting properties
US12195456B1 · kind B1 · utility
0Cited by
1References
9Claims
0Family size
Inventors
Key dates
| Filing date | Oct 9, 2020 |
| Grant date | Jan 14, 2025 |
| Priority date | — |
| Expiry date | Mar 22, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A series of molecules designed to block CDK4/CDK6, with preferentially stronger inhibitory potency against CDK4 is described. The identification of a lead molecule with triple CDK4, CDK6 and PLK1-targeting potency is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.